| センター供給条件 |
供給依頼があった場合、当方への連絡が必要。
及び以下の文献の引用が必要です。
文献：Inoue S, Inoue M, Fujimura S, and Nishinakamura R.A mouse line expressing Sall1-driven inducible Cre recombinase in the kidney mesenchyme. Genesis 48: 207-212, 2010.
GIE-CERBM (IGBMC) has designed the Cre-ERT2 construct and has been granted an US patent (No7112715) and an European patent (NoIB01/02246) that cover the use of Cre-ERT2 transgenic mice.
Kumamoto University may transfer MATERIAL, MODIFICATIONS, and/or derived Cre-ERT2-containing transgenic mice to other scientists at non-profit institutions ("Collaborator") for non-industrially sponsored research, non-commercial, internal, and academic research if, and only if, Collaborator has obtained a Cre-ERT2 MTA from IGBMC (please contact chambon@igbmc.fr to obtain a copy of the MTA).
|